Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4776
American Century Quality Diversified International ETF
QINT
$699M
| $2.81M | ﹤0.01% |
+71,881
| New | +$3.08M |
|
4777
PUT
Invesco CurrencyShares Australian Dollar Trust
FXA
$94.9M
| $2.81M | ﹤0.01% |
41,100
+34,100
| +487% | +$2.41M |
|
|
RDUS
4778
DELISTED
Radius Health, Inc.
RDUS
| $2.81M | ﹤0.01% |
270,747
-37,891
| -12% | -$282K |
|
4779
Banco Santander Chile
BSAC
$16.3B
| $2.81M | ﹤0.01% |
172,234
-218,221
| -56% | -$4.24M |
|
4780
John B. Sanfilippo & Son
JBSS
$979M
| $2.81M | ﹤0.01% |
38,715
-1,562
| -4% | -$119K |
|
4781
CALL
Service Corp International
SCI
$11.2B
| $2.81M | ﹤0.01% |
40,600
-75,700
| -65% | -$5.18M |
|
|
SNV
4782
CALL
DELISTED
Synovus
SNV
| $2.81M | ﹤0.01% |
77,800
+1,200
| +2% | +$49.6K |
|
|
FAX
4783
abrdn Asia-Pacific Income Fund
FAX
$603M
| $2.8M | ﹤0.01% |
160,068
-782
| -0.5% | -$14.6K |
|
4784
PUT
KeyCorp
KEY
$24.7B
| $2.8M | ﹤0.01% |
162,600
-41,500
| -20% | -$802K |
|
4785
CALL
Halozyme
HALO
$11.7B
| $2.8M | ﹤0.01% |
63,600
+8,600
| +16% | +$372K |
|
|
GTLS
4786
CALL
DELISTED
Chart Industries
GTLS
| $2.79M | ﹤0.01% |
16,700
-11,800
| -41% | -$2.02M |
|
|
EWCZ
4787
DELISTED
European Wax Center
EWCZ
| $2.79M | ﹤0.01% |
158,463
+85,857
| +118% | +$2.19M |
|
4788
PUT
Universal Health Services
UHS
$10.1B
| $2.79M | ﹤0.01% |
27,700
-33,800
| -55% | -$4.23M |
|
|
JNPR
4789
PUT
DELISTED
Juniper Networks
JNPR
| $2.78M | ﹤0.01% |
97,600
+21,000
| +27% | +$662K |
|
4790
CALL
Lear
LEA
$8.31B
| $2.78M | ﹤0.01% |
22,100
-3,300
| -13% | -$435K |
|
4791
PUT
Lamb Weston
LW
$7.22B
| $2.78M | ﹤0.01% |
38,900
-800
| -2% | -$52.8K |
|
4792
CALL
Amplify Blockchain Technology ETF
BLOK
$1.09B
| $2.78M | ﹤0.01% |
153,200
+15,400
| +11% | +$377K |
|
4793
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.6B
| $2.78M | ﹤0.01% |
75,423
+42,931
| +132% | +$1.7M |
|
4794
Vipshop
VIPS
$6.74B
| $2.78M | ﹤0.01% |
280,688
+54,314
| +24% | +$478K |
|
|
MAXR
4795
CALL
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $2.78M | ﹤0.01% |
106,400
+9,100
| +9% | +$283K |
|
4796
Bionano Genomics
BNGO
$14M
| $2.77M | ﹤0.01% |
3,348
+2,061
| +160% | +$2.12M |
|
4797
CALL
GDS Holdings
GDS
$7.09B
| $2.77M | ﹤0.01% |
83,000
-204,100
| -71% | -$6.34M |
|
4798
iShares MSCI Japan Value ETF
EWJV
$780M
| $2.77M | ﹤0.01% |
117,386
+35,680
| +44% | +$894K |
|
4799
Oil States International
OIS
$553M
| $2.77M | ﹤0.01% |
511,036
+423,888
| +486% | +$2.96M |
|
|
ODP
4800
DELISTED
ODP
ODP
| $2.77M | ﹤0.01% |
+91,589
| New | +$3.7M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.